All In Biotech

Investigational drug · Phase 2

SYS6090

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for HCC - Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer.

Phase 2

Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

3

3 still active

All registered trials

3

Any phase or sponsor naming "SYS6090"

First trial start

2026

Feb 28, 2026

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "SYS6090", any sponsor or status.

Conditions studied

As listed on its trial records.

  • HCC - Hepatocellular Carcinoma
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Unresectable Advanced or Metastatic Colorectal Cancer

Approved drugs for the same conditions: Non-small cell lung cancer · Small cell lung cancer · Colorectal cancer · Liver cancer (hepatocellular carcinoma) · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "SYS6090" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for HCC - Hepatocellular Carcinoma

  • SintilimabIBI308Phase 321 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Hepatocellular Carcinoma, Solid Tumor, HCC - Hepatocellular Carcinoma

  • SYS6043Phase 35 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Advanced/Metastatic Solid Tumors, HCC - Hepatocellular Carcinoma

  • AST-3424Phase 22 trials

    Zhejiang Hisun Pharmaceutical Co. Ltd. · HCC - Hepatocellular Carcinoma, Advanced Solid Tumors, Hepatocellular Carcinoma

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.